{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T22:32:27Z","timestamp":1792103547628,"version":"4.4.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.bbrc.2026.154365","type":"journal-article","created":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T06:38:34Z","timestamp":1785307114000},"page":"154365","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["AC137932.2 reinforces hypoxia-driven glycolytic remodeling in triple-negative breast cancer through an IGF2BP2\/HIF-1\u03b1 positive feedback loop"],"prefix":"10.1016","volume":"832","author":[{"given":"Wenliang","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziming","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-2880-0489","authenticated-orcid":false,"given":"Ran","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2026.154365_bib1","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/s41523-022-00468-0","article-title":"Triple negative breast cancer: pitfalls and progress","volume":"8","author":"Zagami","year":"2022","journal-title":"npj Breast Cancer"},{"key":"10.1016\/j.bbrc.2026.154365_bib2","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/s41523-023-00554-x","article-title":"Rare subtypes of triple negative breast cancer: current understanding and future directions","volume":"9","author":"Thomas","year":"2023","journal-title":"npj Breast Cancer"},{"key":"10.1016\/j.bbrc.2026.154365_bib3","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1038\/s41586-023-06498-3","article-title":"Spatial predictors of immunotherapy response in triple-negative breast cancer","volume":"621","author":"Wang","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2026.154365_bib4","article-title":"Spatial transcriptomics reveals substantial heterogeneity in triple-negative breast cancer with potential clinical implications","volume":"15","author":"Wang","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbrc.2026.154365_bib5","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ccell.2023.12.012","article-title":"Single-cell and spatial profiling identify three response trajectories to pembrolizumab and radiation therapy in triple negative breast cancer","volume":"42","author":"Shiao","year":"2024","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbrc.2026.154365_bib6","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/s41392-023-01332-8","article-title":"Hypoxic microenvironment in cancer: molecular mechanisms and therapeutic interventions","volume":"8","author":"Chen","year":"2023","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.bbrc.2026.154365_bib7","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1038\/s41416-021-01630-4","article-title":"Breast cancer hypoxia in relation to prognosis and benefit from radiotherapy after breast-conserving surgery in a large, randomised trial with long-term follow-up","volume":"126","author":"Tutzauer","year":"2022","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bbrc.2026.154365_bib8","doi-asserted-by":"crossref","first-page":"4118","DOI":"10.1038\/s41467-022-31764-9","article-title":"Hypoxia induces HIF1\u03b1-dependent epigenetic vulnerability in triple negative breast cancer to confer immune effector dysfunction and resistance to anti-PD-1 immunotherapy","volume":"13","author":"Ma","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbrc.2026.154365_bib9","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s12943-024-01975-3","article-title":"LINC00115 promotes chemoresistant breast cancer stem-like cell stemness and metastasis through SETDB1\/PLK3\/HIF1\u03b1 signaling","volume":"23","author":"Luo","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bbrc.2026.154365_bib10","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1038\/s44318-024-00065-w","article-title":"Metabolic priming by multiple enzyme systems supports glycolysis, HIF1\u03b1 stabilisation, and human cancer cell survival in early hypoxia","volume":"43","author":"Grimm","year":"2024","journal-title":"EMBO J."},{"key":"10.1016\/j.bbrc.2026.154365_bib11","doi-asserted-by":"crossref","first-page":"3445","DOI":"10.1038\/s41467-024-47536-6","article-title":"Wild-type IDH2 is a therapeutic target for triple-negative breast cancer","volume":"15","author":"Li","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbrc.2026.154365_bib12","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s13058-024-01854-1","article-title":"Hypoxia-mediated repression of pyruvate carboxylase drives immunosuppression","volume":"26","author":"Coleman","year":"2024","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.bbrc.2026.154365_bib13","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1158\/0008-5472.CAN-21-1179","article-title":"Low glucose-induced overexpression of HOXC-AS3 promotes metabolic reprogramming of breast cancer","volume":"82","author":"Zhu","year":"2022","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbrc.2026.154365_bib14","doi-asserted-by":"crossref","first-page":"7160","DOI":"10.1038\/s41467-022-34702-x","article-title":"Long noncoding RNA DIO3OS induces glycolytic-dominant metabolic reprogramming to promote aromatase inhibitor resistance in breast cancer","volume":"13","author":"Chen","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbrc.2026.154365_bib15","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1080\/15384101.2022.2040283","article-title":"LncRNA LINC00649 promotes the growth and metastasis of triple-negative breast cancer by maintaining the stability of HIF-1\u03b1 through the NF90\/NF45 complex","volume":"21","author":"Zhang","year":"2022","journal-title":"Cell Cycle"},{"key":"10.1016\/j.bbrc.2026.154365_bib16","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-00364-w","article-title":"The nomogram based on the 6-lncRNA model can promote the prognosis prediction of patients with breast invasive carcinoma","volume":"11","author":"Luo","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbrc.2026.154365_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.113972","article-title":"Hypoxia-inducible factor 1 recruits FACT and RNF20\/40 to mediate histone ubiquitination and transcriptional activation of target genes","volume":"43","author":"Lyu","year":"2024","journal-title":"Cell Rep."},{"key":"10.1016\/j.bbrc.2026.154365_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.mam.2024.101249","article-title":"Improving the quality of quantitative polymerase chain reaction experiments: 15 years of MIQE","volume":"96","author":"Bustin","year":"2024","journal-title":"Mol. Aspect. Med."},{"key":"10.1016\/j.bbrc.2026.154365_bib19","first-page":"113","article-title":"Mesenchymal stem cells cause telomere length reduction of molt-4 cells via caspase-3, BAD and P53 apoptotic pathway","volume":"10","author":"Heidari","year":"2021","journal-title":"Int. J. Molecul. Cell. Med."},{"key":"10.1016\/j.bbrc.2026.154365_bib20","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1186\/s12885-023-11552-4","article-title":"Downregulation of TAB182 promotes cancer stem-like cell properties and therapeutic resistance in triple-negative breast cancer cells","volume":"23","author":"He","year":"2023","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bbrc.2026.154365_bib21","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/s41419-024-06829-w","article-title":"ADT-OH exhibits anti-metastatic activity on triple-negative breast cancer by combinatorial targeting of autophagy and mitochondrial fission","volume":"15","author":"Yu","year":"2024","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbrc.2026.154365_bib22","article-title":"A1BG-AS1 promotes adriamycin resistance of breast cancer by recruiting IGF2BP2 to upregulate ABCB1 in an m6A-dependent manner","volume":"13","author":"Wang","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbrc.2026.154365_bib23","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1038\/s41467-021-21535-3","article-title":"The HIF-1\u03b1 antisense long non-coding RNA drives a positive feedback loop of HIF-1\u03b1 mediated transactivation and glycolysis","volume":"12","author":"Zheng","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbrc.2026.154365_bib24","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.580176","article-title":"Long noncoding RNA MIR210HG promotes the warburg effect and tumor growth by enhancing HIF-1\u03b1 translation in triple-negative breast cancer","volume":"10","author":"Du","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbrc.2026.154365_bib25","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/ncb3295","article-title":"The LINK-A lncRNA activates normoxic HIF1\u03b1 signalling in triple-negative breast cancer","volume":"18","author":"Lin","year":"2016","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.bbrc.2026.154365_bib26","article-title":"LncRNA GHET1 promotes hypoxia-induced glycolysis, proliferation, and invasion in triple-negative breast cancer through the Hippo\/YAP signaling pathway","volume":"9","author":"Wang","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.bbrc.2026.154365_bib27","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/s41420-024-02058-4","article-title":"The lncRNAMALAT1-WTAP axis: a novel layer of EMT regulation in hypoxic triple-negative breast cancer","volume":"10","author":"Dragonetti","year":"2024","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.bbrc.2026.154365_bib28","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1111\/cas.15370","article-title":"LINC01605 promotes aerobic glycolysis through lactate dehydrogenase A in triple\u2010negative breast cancer","volume":"113","author":"Wang","year":"2022","journal-title":"Cancer Sci."},{"key":"10.1016\/j.bbrc.2026.154365_bib29","doi-asserted-by":"crossref","DOI":"10.4028\/b-XDTcg5","article-title":"METTL14\u2010Mediated M6A modification of LINC01094 induces glucose metabolic reprogramming in breast cancer by recruiting the PKM2\/JMJD5 complex","volume":"12","author":"Wang","year":"2025","journal-title":"Adv. Sci."},{"key":"10.1016\/j.bbrc.2026.154365_bib30","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s12943-024-02037-4","article-title":"Exosomal circSIPA1L3-mediated intercellular communication contributes to glucose metabolic reprogramming and progression of triple negative breast cancer","volume":"23","author":"Liang","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bbrc.2026.154365_bib31","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.gendis.2023.06.017","article-title":"IGF2BPs as novel m6A readers: diverse roles in regulating cancer cell biological functions, hypoxia adaptation, metabolism, and immunosuppressive tumor microenvironment","volume":"11","author":"Duan","year":"2024","journal-title":"Genes Dis."},{"key":"10.1016\/j.bbrc.2026.154365_bib32","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/s41388-024-03213-y","article-title":"Hypoxia induced cellular and exosomal RPPH1 promotes breast cancer angiogenesis and metastasis through stabilizing the IGF2BP2\/FGFR2 axis","volume":"44","author":"Ning","year":"2025","journal-title":"Oncogene"},{"key":"10.1016\/j.bbrc.2026.154365_bib33","doi-asserted-by":"crossref","first-page":"674","DOI":"10.3390\/cells12040674","article-title":"Recent clinical advances on long non-coding RNAs in triple-negative breast cancer","volume":"12","author":"Singh","year":"2023","journal-title":"Cells"}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X26011290?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X26011290?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T04:19:01Z","timestamp":1788063541000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X26011290"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":33,"alternative-id":["S0006291X26011290"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2026.154365","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"AC137932.2 reinforces hypoxia-driven glycolytic remodeling in triple-negative breast cancer through an IGF2BP2\/HIF-1\u03b1 positive feedback loop","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2026.154365","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"154365"}}